Sponsor:
University of Pennsylvania
Code:
NCT07798700
Conditions
Frontotemporal Degeneration (FTD)
ALS (Amyotrophic Lateral Sclerosis)
Primary Progressive Aphasia (PPA)
Familial Frontotemporal Lobar Degeneration (fFTLD)
Fronto-temporal Lobar Dementia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Frontotemporal Degeneration (FTD)
ALS (Amyotrophic Lateral Sclerosis)
Primary Progressive Aphasia (PPA)
Familial Frontotemporal Lobar Degeneration (fFTLD)
Fronto-temporal Lobar Dementia
Study ID
NCT07798700
Start date
Dec 12, 2025
Status verified date
Aug, 2026
Completion date
Jan 1, 2070
Anticipated
Primary completion date
Jan 1, 2070
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
1000 participants
Anticipated
Arms
People with a clinical diagnosis of neurodegenerative disease
Family members of individuals meeting criteria for group 1
Healthy Controls
Primary outcome measure
Central contacts
Locations
University of Pennsylvania
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Emily Xie
emily.xie@pennmedicine.upenn.eduPrincipal Investigator:
Corey McMillan, PhD
Sponsor
University of Pennsylvania
Last update posted
Sep 1, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2026-09-01.